Cargando…

Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting

OBJECTIVES: This systematic review focuses on the use of the in vitro hollow fibre infection model (HFIM) for microbial culture. We summarize the direction of the field to date and propose best-practice principles for reporting of the applications. METHODS: Searches in six databases (MEDLINE(®), EMB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadouki, Zahra, McHugh, Timothy D., Aarnoutse, Rob, Ortiz Canseco, Julio, Darlow, Christopher, Hope, William, van Ingen, Jakko, Longshaw, Christopher, Manissero, Davide, Mead, Andrew, Pelligand, Ludovic, Phee, Lynette, Readman, John, Ruth, Mike M., Standing, Joseph F., Stone, Neil, Wey, Emmanuel Q., Kloprogge, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361333/ https://www.ncbi.nlm.nih.gov/pubmed/34179966 http://dx.doi.org/10.1093/jac/dkab160

Ejemplares similares

Applications of the hollow-fibre infection model (HFIM) in viral infection studies
por: Kembou-Ringert, Japhette E, et al.
Publicado: (2022)

Improving the Drug Development Pipeline for Mycobacteria: Modelling Antibiotic Exposure in the Hollow Fibre Infection Model
por: Maitra, Arundhati, et al.
Publicado: (2021)

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis
por: Kloprogge, Frank, et al.
Publicado: (2022)

Antiviral Effects of Clinically-Relevant Interferon-α and Ribavirin Regimens against Dengue Virus in the Hollow Fiber Infection Model (HFIM)
por: Pires de Mello, Camilly P., et al.
Publicado: (2018)

Fosfomycin (FOS) Plus Meropenem (MER) Suppresses Resistance Emergence Against P. aeruginosa (PA) PAO1 in the Hollow Fiber Infection Model (HFIM)
por: Louie, Arnold, et al.
Publicado: (2017)

1379. Determination of the Arbekacin Exposure Required to Prevent Amplification of Resistant Subpopulations Using Patient Pharmacokinetics Simulated in a Hollow-Fiber Infection Model (HFIM)
por: VanScoy, Brian D, et al.
Publicado: (2018)

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii
por: Phee, Lynette M, et al.
Publicado: (2019)

In vitro activity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
por: Longshaw, Christopher, et al.
Publicado: (2020)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Pharmacokinetics of Colistin in the Gastrointestinal Tract of Poultry Following Dosing via Drinking Water and Its Bactericidal Impact on Enteric Escherichia coli
por: Mead, Andrew, et al.
Publicado: (2021)

1263. Assessment of Cefepime (FEP)-Taniborbactam (TAN) Human Exposures to Suppress the Emergence of Resistance among Serine (SBL)- and Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacteria (GNB) in a Hollow Fiber Infection Model (HFIM)
por: Avery, Lindsay M, et al.
Publicado: (2020)

2792. Determining the activity of imipenem/relebactam (I/R) plus aztreonam (ATM) against constitutive Pseudomonas derived cephalosporinase (PDC)- and metallo-β-lactamase (MBL)-producing Pseudomonas aeruginosa in a hollow fiber infection model (HFIM)
por: O’Donnell, J Nicholas, et al.
Publicado: (2023)

Quantitative Pharmacodynamic Characterization of Resistance versus Heteroresistance of Colistin in E. coli Using a Semimechanistic Modeling of Killing Curves
por: Mead, Andrew, et al.
Publicado: (2022)

Targeted dosing for susceptible heteroresistant subpopulations may improve rational dosage regimen prediction for colistin in broiler chickens
por: Mead, Andrew, et al.
Publicado: (2023)

Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings
por: Darlow, Christopher A, et al.
Publicado: (2022)

Insights into the clinical management of carbapenemresistant Gram-negative infections: An Italian retrospective clinical chart review
por: Granata, Guido, et al.
Publicado: (2020)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2021)

Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales—authors’ response
por: Darlow, Christopher A, et al.
Publicado: (2022)

Correction to: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales
por: Darlow, Christopher A, et al.
Publicado: (2022)

Time-Kill Analysis of Canine Skin Pathogens: A Comparison of Pradofloxacin and Marbofloxacin
por: Azzariti, Stefano, et al.
Publicado: (2023)

Characterization of Mycobacterium orygis
por: van Ingen, Jakko, et al.
Publicado: (2013)

Mimicking in-vivo exposures to drug combinations in-vitro: anti-tuberculosis drugs in lung lesions and the hollow fiber model of infection
por: Kloprogge, Frank, et al.
Publicado: (2019)

High-dose rifampicin in tuberculosis: Experiences from a Dutch tuberculosis centre
por: Seijger, Charlotte, et al.
Publicado: (2019)

Determination of colistin in luminal and parietal intestinal matrices of chicken by ultra‐high‐performance liquid chromatography‐tandem mass spectrometry
por: Mead, Andrew, et al.
Publicado: (2021)

Population Pharmacokinetics of Intraventricular Vancomycin in Neonatal Ventriculitis, A Preterm Pilot Study
por: Parasuraman, Jaya Madhura, et al.
Publicado: (2021)

Recent Developments in Mycobacteriology: A Clinical and Diagnostic Perspective
por: Jagielski, Tomasz, et al.
Publicado: (2014)

Species Distribution and Isolation Frequency of Nontuberculous Mycobacteria, Uruguay
por: Greif, Gonzalo, et al.
Publicado: (2020)

Epidemiological Prevalence of Phenotypical Resistances and Mobilised Colistin Resistance in Avian Commensal and Pathogenic E. coli from Denmark, France, The Netherlands, and the UK
por: Mead, Andrew, et al.
Publicado: (2022)

2447. Ertapenem and Faropenem for the Treatment of Drug-Resistant Tuberculosis
por: Satta, Giovanni, et al.
Publicado: (2018)

Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey
por: Wagner, Dirk, et al.
Publicado: (2020)

Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration
por: Kenward, Hannah, et al.
Publicado: (2014)

Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling
por: Dorey, Lucy, et al.
Publicado: (2017)

Global survey of physician testing practices for nontuberculous mycobacteria
por: Loebinger, Michael R., et al.
Publicado: (2023)

Microfluidic manipulation by spiral hollow-fibre actuators
por: Li, Sitong, et al.
Publicado: (2022)

Thermal Profiles of Chainsaw Hollows and Natural Hollows during Extreme Heat Events
por: Callan, Michael N., et al.
Publicado: (2023)

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections
por: Chalmers, James D., et al.
Publicado: (2021)

Comparative assessment of viral dynamic models for SARS‐CoV‐2 for pharmacodynamic assessment in early treatment trials
por: Agyeman, Akosua A., et al.
Publicado: (2022)

Otomastoiditis Caused by Mycobacterium abscessus, the Netherlands
por: van Ingen, Jakko, et al.
Publicado: (2010)

Current Methods in the Molecular Typing of Mycobacterium tuberculosis and Other Mycobacteria
por: Jagielski, Tomasz, et al.
Publicado: (2014)

Outbreaks of healthcare-associated infections linked to water-containing hospital equipment: a literature review
por: Yiek, Wing-Kee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_063epie0lmf7q6j9fo4gjduesn